A novel calcium receptor active compound having the formula is provided:

wherein:

  • Ar1 is selected from the group consisting of aryl, heteroaryl, bis(arylmethyl)amino, bis(heteroarylmethyl)amino and arylmethyl(heteroarylmethyl)amino;
  • X is selected from the group consisting of oxygen, sulfur, sulfinyl, sulfonyl, carbonyl and amino;
  • R1, R2, R3, R4, R5, R6, R7, R8 and R9 are, for example, hydrogen or alkyl;
  • Ar2 is selected from the group consisting of aryl and heteroaryl;
  • p is an integer of from 0 to 6, inclusive; and,
  • q is an integer of from 0 to 14, inclusive.
  •  
    Web www.patentalert.com

    < Combination therapy for conditions leading to bone loss

    < Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith

    > Human protein phosphatase 2C

    > 3-aryl-hydroxybenzoxazines and 3, 4-dihydro-3-aryl-hydroxybenzoxazines as selective estrogen receptor beta modulators

    ~ 00205